Your browser does not support JavaScript or it may be disabled!
rediff.com
 India As It Happens
Rediff Labs will showcase innovative products that rediff is working on behind the scenes.
News   |   Images
NEWS ON MOBILE
Get Realtime News
on your webpage

About 142 results for "sarabjit kour nangra"

Infosys guidance a sure sign that they mean business: Sarabjit...

They have been guiding again and again that FY17 onwards, they expect Infosys to be back being the bellwether company in terms of the IT sector. In an interview with ET Now, Sarabjit Kour Nangra, VP - Research, Angel Broking, shares her views on the Infosys ... Economic Times, 4 days ago

2 images for "sarabjit kour nangra"

Business Standard, 3 months ago
Times of India, 5 months ago
DNA

HCL Tech shares tank nearly 10% as Q3 earnings disappoint

"HCL Technologies announced its Q3 FY'15 results below expectations," said Sarabjit Kour Nangra, VP Research - IT, Angel Broking.
 DNA1 week ago HCL Tech shares end nearly 4% lower as Q3 earnings disappoint  Economic Times1 week ago
Sify

Infosys looks to post $20b sales by 20

MUMBAI Infosys, India's second-largest software services exporter, posted quarterly net profit that lagged most analyst expectations, dampening hopes of a quick turnaround after top management changes. Bengaluru-based Infosys, once seen as the ...
 Oman Tribune2 days ago Infosys Offers 1:1 Bonus, Net Profit up 3.6 Percentage in Q4  New Indian Express3 days ago Infosys Q4 results: Vishal Sikka's 20/20 vision  Financial Express4 days ago Infosys bets on new services to push sales to $20 bln by 2020  Sharenet4 days ago
[x]  

Infosys’ Q4 PAT rises 3.5%, investors upset

IT major Infosys reported 3.5 per cent annual increase in net profit to Rs 3,097 crore for the quarter ended March 31, 2014. The company’s revenue for the quarter rose 4.2 per cent to Rs 13,411 crore. For the full financial year (2014-15), the company’s ...
 The Financial Chronicle4 days ago Infosys slips 6%, fails to cheer Dalal Street post Q4 results; here's what experts say  Economic Times4 days ago

Infosys: Analysts bullish on the path CEO Sikka is taking

The disappointing results Infosys has posted raise concerns in the near term, but industry watchers are bullish about the path laid out by Chief Executive Vishal Sikka. During the results, Infosys announced two developments — an acquisition and ...
 Hindu Business Line4 days ago Wipro bullish in near term  Hindu Business Line1 month ago

Infosys dives 6% post poor Q4 results; TCS gains 2%

Shares of Infosys took a knock after its March quarter earnings disappointed investor sentiments. Falling 7 percent intraday Friday, the stock ended down 6 percent at Rs 1996.25 on the BSE. IT index slipped 3 percent from its previous close. ...
 Moneycontrol.com4 days ago Wipro cracks 4% intraday post Q4 earnings  Economic Times6 days ago Wipro cracks over 6% intraday post Q4 earnings  Economic Times6 days ago Wipro cracks over 5% intraday post Q4 earnings  Economic Times6 days ago

Wipro ends day 6% down despite in-line Q4 earnings

BANGALORE: Stocks of Wipro Ltd fell over 6 per cent in intraday trade on Wednesday after the company announced its quarterly earnings on Tuesday. The country's third largest software services firm posted a net profit of Rs 2,286.5 crore in ...
 Economic Times6 days ago
Livemint.com

HCL Tech Profit up 3.6 Percent in Q3

HCL Technologies has reported a consolidated net profit of Rs 1,683 crore during the third quarter ended March 31, up 3.6 percent against Rs 1,624 crore in the corresponding period last year. Led by geographical growth in both Europe and the US, ...
 Communications Today6 days ago HCL Technologies Q3 profit rises 3.6%, misses estimates  Livemint.com6 days ago

Wipro cracks 4% despite in-line Q4; what experts says

BANGALORE: Stocks of Wipro Ltd fell as much as 4 per cent in intraday trade on Wednesday after the company announced its quarterly earnings on Tuesday. The country's third largest software services firm posted a net profit of Rs 2,286.5 crore in January-March ...
 Economic Times6 days ago

Dr Reddy's banks on acquisitions for growth

Earlier this month, Dr Reddy's Laboratories entered into an agreement to acquire 23 select products from Belgian biopharmaceutical firm UCB in the territories of India, Nepal, Sri Lanka and the Maldives for about euro 128 million (Rs800 crore). This ...
 Business Standard India1 week ago Dr Reddy's to buy select brands of biopharma firm UCB for Rs 800 cr  Smart Investor3 weeks ago
Prev | Next
Personalize your Realtimeclose [x]
Add content to your personalized tab - My News
Add upto 6 topics of your interest:
for eg.2g Scam , World
1.
2.
3.
4.
5.
6.
Personalize the tabs display. ( You can add or remove the tabs )
AlertsGet updates on latest news & your favourite topics right in your inbox.Set an Alert|Manage your Alerts

Get

Realtime News

on your Webpage

Add Widget >Get your members hooked!
Related Queries - sarabjit kour nangra
    
Alerts
Get updated on latest news & your favorite topics right in your inbox!
 
More     Less